Clinical Trial Update: A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial updating the evaluation of PF-04449913 in combination with chemotherapy for acute myeloid leukemia, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• PF-04449913

Snippet

Sponsor: Pfizer | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-05-23